Literature DB >> 30132047

Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

S Hüser1, S Guth1, H G Joost2, S T Soukup3, J Köhrle4, L Kreienbrock5, P Diel6, D W Lachenmeier7, G Eisenbrand8, G Vollmer9, U Nöthlings10, D Marko11, A Mally12, T Grune13, L Lehmann14, P Steinberg15,16, S E Kulling17.   

Abstract

Isoflavones are secondary plant constituents of certain foods and feeds such as soy, linseeds, and red clover. Furthermore, isoflavone-containing preparations are marketed as food supplements and so-called dietary food for special medical purposes to alleviate health complaints of peri- and postmenopausal women. Based on the bioactivity of isoflavones, especially their hormonal properties, there is an ongoing discussion regarding their potential adverse effects on human health. This review evaluates and summarises the evidence from interventional and observational studies addressing potential unintended effects of isoflavones on the female breast in healthy women as well as in breast cancer patients and on the thyroid hormone system. In addition, evidence from animal and in vitro studies considered relevant in this context was taken into account along with their strengths and limitations. Key factors influencing the biological effects of isoflavones, e.g., bioavailability, plasma and tissue concentrations, metabolism, temporality (pre- vs. postmenopausal women), and duration of isoflavone exposure, were also addressed. Final conclusions on the safety of isoflavones are guided by the aim of precautionary consumer protection.

Entities:  

Keywords:  Breast tissue; Human intervention studies; Isoflavones; Observational studies; Safety evaluation; Thyroid hormone system

Mesh:

Substances:

Year:  2018        PMID: 30132047      PMCID: PMC6132702          DOI: 10.1007/s00204-018-2279-8

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  281 in total

1.  Soy-derived isoflavones treatment in children with hypercholesterolemia: a pilot study.

Authors:  Amnon Zung; Sabina Shachar; Zvi Zadik; Zohar Kerem
Journal:  J Pediatr Endocrinol Metab       Date:  2010 Jan-Feb       Impact factor: 1.634

2.  Soy protein infant formulae and follow-on formulae: a commentary by the ESPGHAN Committee on Nutrition.

Authors:  Carlo Agostoni; Irene Axelsson; Olivier Goulet; Berthold Koletzko; Kim Fleischerm Michaelsen; John Puntis; Daniel Rieu; Jacques Rigo; Raanan Shamir; Hania Szajewska; Dominique Turck
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-04       Impact factor: 2.839

3.  Erratum to: Phase II metabolism of the soy isoflavones genistein and daidzein in humans, rats and mice: a cross-species and sex comparison.

Authors:  Sebastian T Soukup; Jussi Helppi; Dennis R Müller; Oliver Zierau; Bernhard Watzl; Günter Vollmer; Patrick Diel; Achim Bub; Sabine E Kulling
Journal:  Arch Toxicol       Date:  2016-06       Impact factor: 5.153

4.  A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intake.

Authors:  Margaret R Ritchie; John H Cummings; Michael S Morton; C Michael Steel; Caroline Bolton-Smith; Andrew C Riches
Journal:  Br J Nutr       Date:  2006-01       Impact factor: 3.718

5.  Recent diet and breast cancer risk: the California Teachers Study (USA).

Authors:  Pamela L Horn-Ross; K J Hoggatt; Dee W West; Melissa R Krone; Susan L Stewart; Hoda Anton; Culver Leslie Bernstei; Dennis Deapen; David Peel; Richard Pinder; Peggy Reynolds; Ronald K Ross; William Wright; Al Ziogas
Journal:  Cancer Causes Control       Date:  2002-06       Impact factor: 2.506

6.  Effect of dietary soy on serum thyroid hormone concentrations in healthy adult cats.

Authors:  Heidi L White; Lisa M Freeman; Orla Mahony; Peter A Graham; Qin Hao; Michael H Court
Journal:  Am J Vet Res       Date:  2004-05       Impact factor: 1.156

7.  Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trial.

Authors:  Elena A Pop; Leslie M Fischer; April D Coan; Matt Gitzinger; Jun Nakamura; Steven H Zeisel
Journal:  Menopause       Date:  2008 Jul-Aug       Impact factor: 2.953

8.  Soy formula complicates management of congenital hypothyroidism.

Authors:  S C Conrad; H Chiu; B L Silverman
Journal:  Arch Dis Child       Date:  2004-01       Impact factor: 3.791

Review 9.  Thyroid hormone regulation of metabolism.

Authors:  Rashmi Mullur; Yan-Yun Liu; Gregory A Brent
Journal:  Physiol Rev       Date:  2014-04       Impact factor: 37.312

Review 10.  Chemical carcinogenesis of rat and mouse mammary glands.

Authors:  Daniel Medina
Journal:  Breast Dis       Date:  2007
View more
  18 in total

1.  Estrogenic in vitro evaluation of zearalenone and its phase I and II metabolites in combination with soy isoflavones.

Authors:  Dino Grgic; Andrea Betschler; Rebeka Früholz; Barbara Novak; Elisabeth Varga; Doris Marko
Journal:  Arch Toxicol       Date:  2022-08-20       Impact factor: 6.168

Review 2.  Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans.

Authors:  Il-Sup Kim
Journal:  Antioxidants (Basel)       Date:  2021-06-30

Review 3.  Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.

Authors:  Victor Stefan Ionescu; Alexandra Popa; Andrei Alexandru; Emilia Manole; Mihaela Neagu; Sevinci Pop
Journal:  Antioxidants (Basel)       Date:  2021-11-26

Review 4.  Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review.

Authors:  Inés Domínguez-López; Maria Yago-Aragón; Albert Salas-Huetos; Anna Tresserra-Rimbau; Sara Hurtado-Barroso
Journal:  Nutrients       Date:  2020-08-15       Impact factor: 5.717

5.  The Effect of High Dose Isoflavone Supplementation on Serum Reverse T3 in Euthyroid Men With Type 2 Diabetes and Post-menopausal Women.

Authors:  Thozhukat Sathyapalan; Josef Köhrle; Eddy Rijntjes; Alan S Rigby; Soha R Dargham; Eric S Kilpatrick; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-22       Impact factor: 5.555

6.  Thyroid Mediation of the Isoflavone Effects on Osteoporotic Bone: The Endocrine Interference With a Beneficial Outcome.

Authors:  Branka Šošić-Jurjević; Vladimir Ajdžanović; Branko Filipović; Walter Severs; Verica Milošević
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-11       Impact factor: 5.555

7.  Soy protein supplementation in men following radical prostatectomy: a 2-year randomized, placebo-controlled clinical trial.

Authors:  Maarten C Bosland; Erika Enk; Joanne Schmoll; Michael J Schlicht; Carla Randolph; Ryan J Deaton; Hui Xie; Anne Zeleniuch-Jacquotte; Ikuko Kato
Journal:  Am J Clin Nutr       Date:  2021-04-06       Impact factor: 7.045

8.  Transcriptional Regulation of the Equol Biosynthesis Gene Cluster in Adlercreutzia equolifaciens DSM19450T.

Authors:  Ana Belén Flórez; Lucía Vázquez; Javier Rodríguez; Begoña Redruello; Baltasar Mayo
Journal:  Nutrients       Date:  2019-04-30       Impact factor: 5.717

Review 9.  Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.

Authors:  Baltasar Mayo; Lucía Vázquez; Ana Belén Flórez
Journal:  Nutrients       Date:  2019-09-16       Impact factor: 5.717

10.  Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis.

Authors:  Yuxia Wei; Jun Lv; Yu Guo; Zheng Bian; Meng Gao; Huaidong Du; Ling Yang; Yiping Chen; Xi Zhang; Tao Wang; Junshi Chen; Zhengming Chen; Canqing Yu; Dezheng Huo; Liming Li
Journal:  Eur J Epidemiol       Date:  2019-11-21       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.